Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells

Journal of Biomedical Materials Research - Part A

Volumn 94, Issue 4, 2010, Pages 1100-1110

  Wang, Bo ^a   Borazjani, Ali ^a   Tahai, Mina ^a   De Jongh Curry, Amy L ^b   Simionescu, Dan T ^c   Guan, Jianjun ^d   To, Filip ^a   Elder, Steve H ^a   Liao, Jun ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

^b University of Memphis   (United States)

^c AMRL   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Cardiac tissue engineering; Decellularization; Myocardial infarction; Porcine myocardial scaffold

Indexed keywords

ACELLULAR TISSUES; ANGIOGENESIS; BONE MARROW; CARDIAC REGENERATION; CARDIAC TISSUE ENGINEERING; CARDIOMYOCYTES; CELLULAR CONTENT; CLINICAL APPLICATION; CULTURE TIME; DECELLULARIZATION; DECELLULARIZED; ENDOTHELIALIZATION; EXTRACELLULAR MATRICES; IMMUNO-HISTOLOGICAL STAINING; MECHANICAL RESPONSE; MONONUCLEAR CELLS; MYOCARDIAL INFARCTION; NATURAL ARCHITECTURE; PORCINE MYOCARDIAL SCAFFOLD; RECELLULARIZATION; SODIUM DODECYL SULFATE; STEM CELL DIFFERENTIATION; TENSILE MODULI; TISSUE CONSTRUCTS; TISSUE REMODELING; VASCULATURE; VENTRICULAR WALLS;

BONE; CELL CULTURE; HEART; SCAFFOLDS; SODIUM; SODIUM SULFATE; STEM CELLS; TENSILE TESTING;

TISSUE ENGINEERING;

TISSUE SCAFFOLD;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW MONONUCLEAR CELL; CELL FUNCTION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DECELLULARIZATION; ENDOTHELIUM CELL; HEART MUSCLE; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; NANOFABRICATION; NONHUMAN; PHENOTYPE; TENSILE STRENGTH; TISSUE ENGINEERING; VASCULARIZATION;

ANIMALS; ANISOTROPY; BONE MARROW CELLS; CELLS, CULTURED; LEUKOCYTES, MONONUCLEAR; MECHANICAL PHENOMENA; MYOCARDIUM; PHENOTYPE; POROSITY; SARCOMERES; STAINING AND LABELING; SUS SCROFA; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77956488608     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32781     Document Type: Article

References (52)

1. American Heart Association. Heart and Stroke Statistical Update. Dallas, TX: American Heart Association; 2002.
2. Cleutjens JP, Blankesteijn WM, Daemen MJ, Smits JF. The infarcted myocardium: Simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res 1999;44:232-241.
3. De Celle T, Cleutjens JP, Blankesteijn WM, Debets JJ, Smits JF, Janssen BJ. Long-term structural and functional consequences of cardiac ischaemia-reperfusion injury in vivo in mice. Exp Physiol 2004;89:605-615. (Pubitemid 39255732)
4. Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A, Granot Y, Cohen S. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 2000;102(19 Suppl 3):III56-III61.
5. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999;79:215-262.
6. Topol EJ. Current status and future prospects for acute myocardial infarction therapy. Circulation 2003;108(16 Suppl 1):III6-III13.
7. Sharma R, Raghubir R. Stem cell therapy: A hope for dying hearts. Stem Cells Dev 2007;16:517-536.
8. Grauss RW, Winter EM, van Tuyn J, Pijnappels DA, Steijn RV, Hogers B, van der Geest RJ, de Vries AA, Steendijk P, van der Laarse A, Gittenberger-de Groot AC, Schalij MJ, Atsma DE. Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction. Am J Physiol Heart Circ Physiol 2007;293:H2438-H2447.
9. Strauer BE, Kornowski R. Stem cell therapy in perspective. Circulation 2003;107:929-934.
10. Ozawa T, Mickle DA, Weisel RD, Koyama N, Wong H, Ozawa S, Li RK. Histologic changes of nonbiodegradable and biodegradable biomaterials used to repair right ventricular heart defects in rats. J Thorac Cardiovasc Surg 2002;124:1157-1164.
11. Ozawa T, Mickle DA, Weisel RD, Koyama N, Ozawa S, Li RK. Optimal biomaterial for creation of autologous cardiac grafts. Circulation 2002;106(12 Suppl 1):I176-I182.
12. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-926.
13. Zimmermann WH, Melnychenko I, Eschenhagen T. Engineered heart tissue for regeneration of diseased hearts. Biomaterials 2004;25:1639-1647. (Pubitemid 38091542)
14. Thompson RB, Emani SM, Davis BH, van den Bos EJ, Morimoto Y, Craig D, Glower D, Taylor DA. Comparison of intracardiac cell transplantation: Autologous skeletal myoblasts versus bone marrow cells. Circulation 2003;108 (Suppl 1):II264-II271.
15. Bursac N, Papadaki M, Cohen RJ, Schoen FJ, Eisenberg SR, Carrier R, Vunjak-Novakovic G, Freed LE. Cardiac muscle tissue engineering: Toward an in vitro model for electrophysiological studies. Am J Physiol 1999;277 (2 Pt 2):H433-H444.
16. Kellar RS, Shepherd BR, Larson DF, Naughton GK, Williams SK. Cardiac patch constructed from human fibroblasts attenuates reduction in cardiac function after acute infarct. Tissue Eng 2005;11:1678-1687.
17. Barandon L, Couffinhal T, Dufourcq P, Alzieu P, Daret D, Deville C, Duplaa C. Repair of myocardial infarction by epicardial deposition of bone-marrow-cell-coated muscle patch in a murine model. Ann Thorac Surg 2004;78:1409-1417.
18. Aboulafia-Etzion S, Leor J, Barbash IM, Battler A. Fixing a failing heart: Molecular and cellular approaches. Harefuah 1999;136:284-288.
19. Wei HJ, Chen CH, Lee WU, Chiu I, Hwang SW, Lin WW, Huang CC, Yeh YC, Chang Y, Sung HW. Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair. Biomaterials 2008;29:3547-3556.
20. Tan MY, Zhi W, Wei RQ, Huang YC, Zhou KP, Tan B, Deng L, Luo JC, Li XQ, Xie HQ, Yang ZM. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 2009;30:3234-3240.
21. Fujimoto KL, Guan J, Oshima H, Sakai T, Wagner WR. In vivo evaluation of a porous, elastic, biodegradable patch for reconstructive cardiac procedures. Ann Thorac Surg 2007;83:648-654.
22. Carrier RL, Papadaki M, Rupnick M, Schoen FJ, Bursac N, Langer R, Freed LE, Vunjak-Novakovic G. Cardiac tissue engineering: Cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng 1999;64:580-589.
23. Birla RK, Borschel GH, Dennis RG, Brown DL. Myocardial engineering in vivo: Formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng 2005;11:803-813.
24. Birla RK, Borschel GH, Dennis RG. In vivo conditioning of tissue-engineered heart muscle improves contractile performance. Artif Organs 2005;29:866-875.
25. Borschel GH, Dow DE, Dennis RG, Brown DL. Tissue-engineered axially vascularized contractile skeletal muscle. Plast Reconstr Surg 2006;117:2235-2242. (Pubitemid 44324261)
26. Vouyouka AG, Powell RJ, Ricotta J, Chen H, Dudrick DJ, Sawmiller CJ, Dudrick SJ, Sumpio BE. Ambient pulsatile pressure modulates endothelial cell proliferation. J Mol Cell Cardiol 1998;30:609-615.
27. Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C, Nurzynska D, Kasahara H, Zias E, Bonafe M, Nadal-Ginard B, Torella D, Nascimbene A, Quaini F, Urbanek K, Leri A, Anversa P. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005;96:127-137.
28. Streeter DD Jr, Hanna WT. Engineering mechanics for successive states in canine left ventricular myocardium. II. Fiber angle and sarcomere length. Circ Res 1973;33:656-664.
29. Streeter DD Jr, Spotnitz HM, Patel DP, Ross J Jr, Sonnenblick EH. Fiber orientation in the canine left ventricle during diastole and systole. Circ Res 1969;24:339-347.
30. Macchiarelli G, Ohtani O. Endomysium in left ventricle. Heart 2001;86:416.
31. Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials 2006;27:3675-3683.
32. Liao J, Joyce EM, Sacks MS. Effects of decellularization on mechanical and structural properties of the porcine aortic valve leaflets. Biomaterials 2008;29:1065-1074. (Pubitemid 50020175)
33. Borschel GH, Huang YC, Calve S, Arruda EM, Lynch JB, Dow DE, Kuzon WM, Dennis RG, Brown DL. Tissue engineering of recellularized small-diameter vascular grafts. Tissue Eng 2005;11:778-786.
34. Borschel GH, Dennis RG, Kuzon WM Jr. Contractile skeletal muscle tissue-engineered on an acellular scaffold. Plast Reconstr Surg 2004;113:595-602; discussion 603-604.
35. Badylak SF, Tullius R, Kokini K, Shelbourne KD, Klootwyk T, Voytik SL, Kraine MR, Simmons C. The use of xenogeneic small intestinal submucosa as a biomaterial for achilles tendon repair in a dog model. J Biomed Mater Res 1995;29:977-985.
36. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA. Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat Med 2008;14:213-221.
37. Grashow JS, Yoganathan AP, Sacks MS. Biaixal stress-stretch behavior of the mitral valve anterior leaflet at physiologic strain rates. Ann Biomed Eng 2006;34:315-325.
38. Robinson KA, Li J, Mathison M, Redkar A, Cui J, Chronos NA, Matheny RG, Badylak SF. Extracellular matrix scaffold for cardiac repair. Circulation 2005;112 (Suppl 9):I135-I143.
39. Zimmermann WH, Eschenhagen T. Cardiac tissue engineering for replacement therapy. Heart Fail Rev 2003;8:259-269. (Pubitemid 36992440)
40. Bursac N, Loo Y, Leong K, Tung L. Novel anisotropic engineered cardiac tissues: Studies of electrical propagation. Biochem Biophys Res Commun 2007;361:847-853.
41. Vogel W, Grunebach F, Messam CA, Kanz L, Brugger W, Buhring HJ. Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica 2003;88:126-133.
42. Wollert KC, Drexler H. Mesenchymal stem cells for myocardial infarction: Promises and pitfalls. Circulation 2005;112:151-153.
43. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-705.
44. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-98.
45. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-1201.
46. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, Martin BJ. Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann Thorac Surg 2002;73:1919-1925; discussion 1926.
47. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, Fuchs S, Epstein SE. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004;109:1543-1549.
48. Chiu CP, Blau HM. 5-Azacytidine permits gene activation in a previously noninducible cell type. Cell 1985;40:417-424.
49. Tomita Y, Makino S, Hakuno D, Hattan N, Kimura K, Miyoshi S, Murata M, Ieda M, Fukuda K. Application of mesenchymal stem cell-derived cardiomyocytes as bio-pacemakers: Current status and problems to be solved. Med Biol Eng Comput 2007;45:209-220. (Pubitemid 46291445)
50. Fukuda K. Regeneration of cardiomyocytes from bone marrow: Use of mesenchymal stem cell for cardiovascular tissue engineering. Cytotechnology 2003;41:165-175.
51. Holmes JW, Borg TK, Covell JW. Structure and mechanics of healing myocardial infarcts. Annu Rev Biomed Eng 2005;7:223-253.
52. Humphery JD. Cardiovascular Solid Mechanics: Cells, Tissues, and Organs. New York: Springer-Verlag; 2002.